ET
ETHZ
FORUM MARKETS Inc
No data for this timeframe.
Vol
Inst. Holders6 funds
Inst. Value$3.1M
Inst. Activity6 buys / 0 sells
Recent Activity
Feb 18, 2026
Insider
Smith Ryan Lewis sold 16,718 shares
Director @ $0.00 ($0.00)
Inst.
VANGUARD GROUP INC — NEW
237,826 shares ($1.2M)
Inst.
MORGAN STANLEY — NEW
141,112 shares ($691.4K)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $1.2M | NEW |
| MORGAN STANLEY | $691.4K | NEW |
| TWO SIGMA INVESTMENTS, LP | $464.9K | NEW |
| BANK OF AMERICA CORP | $463.0K | NEW |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $335.4K | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Feb 18, 2026 | Smith Ryan | J | $0.00 |
6 institutional holders with $3.1M total value (639,049 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, TWO. Net buying activity: 6 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 237,826 | $1.2M | 37.2% | NEW |
| 2 | MORGAN STANLEY | 141,112 | $691.4K | 22.1% | NEW |
| 3 | TWO SIGMA INVESTMENTS, LP | 94,876 | $464.9K | 14.8% | NEW |
| 4 | BANK OF AMERICA CORP /DE/ | 94,497 | $463.0K | 14.8% | NEW |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 68,450 | $335.4K | 10.7% | NEW |
| 6 | WELLS FARGO & COMPANY/MN | 2,288 | $11.2K | 0.4% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | NEW | — | 237,826 | — | $1.2M | 2025-Q4 |
| MORGAN STANLEY | NEW | — | 141,112 | — | $691.4K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 94,876 | — | $464.9K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | NEW | — | 94,497 | — | $463.0K | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 68,450 | — | $335.4K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | NEW | — | 2,288 | — | $11.2K | 2025-Q4 |
1 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Smith Ryan Lewis | Director | J | 16,718 | $0.00 | $0.00 |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2023-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2023-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.